Axon 2624
CAS [1404506-35-9]
MF C21H19ClN4OMW 378.85
BF844 is a stabilizer of CLRN1N48K in vitro and in vivo. BF844 effectively attenuated progressive hearing loss and prevented deafness in an Usher syndrome type III (USH3) mouse model.
KEYWORDS:BF844 | supplier | CLRN1-N48K stabilizer | BF-844 | BF 844 | CAS [1404506-35-9] | CLRN | Stabilizer
KN Alagramam et al. A small molecule mitigates hearing loss in a mouse model of Usher syndrome III. Nat Chem Biol. 2016 Jun;12(6):444-51. |
1-(4-chloro-3,5-diphenyl-1H-pyrazolo[3,4-c]pyridazin-1-yl)-2-methylpropan-2-ol
[1404506-35-9]
Axon Medchem的业务之一,是独有的Axon Ligands配体库,在世界范围内,被认为是药物研发的标准。这其中,针对850余种生物靶标(包括细胞信号、基因转录、凋亡、细胞周期调控、CNS等),Axon Medchem拥有多达2000余种小分子抑制剂或调节剂。除了配体库,Axon Medchem还是欧洲著名的CRO公司,主要针对生物活性分子和药物类似分子展开合成及协议开发工作,在过去的10年中,Axon Medchem已经发现了多种潜在药物分子,并在生物医药界享有一定的声誉。